E09.3523 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Proliferative Diabetic Retinopathy with Traction Retinal Detachment Involving the Macula, Bilateral (ICD-10 Code: E09.3523)

Summary

Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to advanced eye complications. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated retinal damage. Proliferative diabetic retinopathy is characterized by abnormal blood vessel growth in the retina, and traction retinal detachment involving the macula occurs when scar tissue pulls the retina away from its normal position, threatening central vision in both eyes.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to proliferative diabetic retinopathy and traction retinal detachment due to damage to blood vessels in the retina and subsequent fibrotic changes.

Risk Factors

Risk factors include prolonged exposure to hyperglycemic-inducing drugs or chemicals, pre-existing insulin resistance, genetic predisposition to diabetes, and poor glycemic control. Bilateral involvement may be more likely in cases of severe or prolonged hyperglycemia, or in individuals with advanced retinopathy.

Symptoms

Symptoms may include blurred or distorted vision, floaters, dark spots in the visual field, and sudden vision loss. Bilateral involvement can lead to symmetric visual impairment, affecting both eyes similarly.

Diagnosis

Diagnosis involves a comprehensive eye exam, including dilated retinal imaging (e.g., fundus photography, optical coherence tomography) to assess retinal changes. Blood tests to confirm hyperglycemia and identify the causative agent (if applicable) are also performed. Documentation of bilateral traction retinal detachment involving the macula is critical.

Treatment Options

Treatment focuses on managing hyperglycemia (e.g., discontinuing the offending agent, glycemic control) and addressing retinal complications. Interventions may include laser photocoagulation, anti-VEGF injections, or surgical repair (e.g., vitrectomy) to reattach the retina and preserve vision.

Prognosis and Follow-Up

Prognosis depends on the severity of retinal damage and timely intervention. Early treatment can stabilize vision, but advanced detachment may result in permanent vision loss. Regular follow-up with an ophthalmologist is essential to monitor retinal changes and adjust management.

Complications

Complications include permanent vision loss, blindness, and progression to other diabetic eye diseases (e.g., macular edema). Bilateral involvement increases the risk of significant visual impairment.

Lifestyle & Prevention

Prevention involves avoiding or minimizing exposure to hyperglycemic-inducing substances. For those at risk, regular eye exams and strict glycemic control are recommended to reduce retinopathy progression.

When to Seek Professional Help

Seek immediate medical attention for sudden vision changes, floaters, or pain. Regular ophthalmologic evaluations are advised for individuals with drug-induced diabetes to detect retinopathy early.

Tips for Medical Coders

Document the bilateral nature of the traction retinal detachment involving the macula and confirm the drug or chemical cause of diabetes. Ensure clinical notes specify the retinal findings and any interventions performed. Code E09.3523 is specific to bilateral involvement; verify laterality and retinal details match the documentation.